Pharmaceutical Innovation Services S.L.

Your end-to-end R&D team

Risk Assessment


  • Active Pharmaceutical ingredient permitted daily exposure (PDE) report
  • Risk analysis reports on the incorporation of a new API to your industrial or pilot manufacturing lines
  • Presence of nitrosamines risk evaluation
  • Risk assessment for preventing cross-contamination
  • Elemental Impurities Risk Asessment